Brief: Viridian Therapeutics Enters Commercial Manufacturing Agreement With Wuxi Biologics On May 24, 2026
26/05/2026 21:12
BRIEF-Viridian Therapeutics Enters Commercial Manufacturing Agreement With Wuxi Biologics On May 24, 2026 May 26 (Reuters) - Viridian Therapeutics Inc VRDN.O:
VIRIDIAN THERAPEUTICS INC - ENTERS COMMERCIAL MANUFACTURING AGREEMENT WITH WUXI BIOLOGICS ON MAY 24, 2026 - SEC FILING
VIRIDIAN THERAPEUTICS INC - WUXI BIOLOGICS TO MANUFACTURE AND SUPPLY VELIGROTUG FOR VIRIDIAN THERAPEUTICS - SEC FILING
Further company coverage: VRDN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Viridian Therapeutics
See all newsViridian Therapeutics signs manufacturing deal with WuXi Biologics for thyroid eye disease drug
Brief: Viridian Therapeutics Enters Commercial Manufacturing Agreement With Wuxi Biologics On May 24, 2026
U.S. STOCKS ON THE MOVE-Krispy Kreme, Tesla, Axon Enterprise
U.S. STOCKS ON THE MOVE-Albemarle, Howmet, Travere Therapeutics
Viridian Therapeutics drops on increased stock, convertible bond offerings